These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26258949)

  • 1. Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis.
    Mueller KE; Fields KA
    PLoS One; 2015; 10(8):e0135295. PubMed ID: 26258949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-Dependent Action of Scc4 Reinforces Control of the Type III Secretion System.
    Gao L; Cong Y; Plano GV; Rao X; Gisclair LN; Schesser Bartra S; Macnaughtan MA; Shen L
    J Bacteriol; 2020 Jul; 202(15):. PubMed ID: 32424009
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and Preliminary Characterization of Novel Type III Secreted Effector Proteins in Chlamydia trachomatis.
    McCaslin PN; Andersen SE; Icardi CM; Faris R; Steiert B; Smith P; Haider J; Weber MM
    Infect Immun; 2023 Jul; 91(7):e0049122. PubMed ID: 37347192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis.
    Weber MM; Bauler LD; Lam J; Hackstadt T
    Infect Immun; 2015 Dec; 83(12):4710-8. PubMed ID: 26416906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of homologs of the Chlamydia trachomatis effector CteG reveals a family of Chlamydiaceae type III secreted proteins that can be delivered into host cells.
    Pereira IS; da Cunha M; Leal IP; Luís MP; Gonçalves P; Gonçalves C; Mota LJ
    Med Microbiol Immunol; 2024 Jul; 213(1):15. PubMed ID: 39008129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis TmeA Directly Activates N-WASP To Promote Actin Polymerization and Functions Synergistically with TarP during Invasion.
    Keb G; Ferrell J; Scanlon KR; Jewett TJ; Fields KA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468693
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
    Fields KA; Hackstadt T
    Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors.
    Parrett CJ; Lenoci RV; Nguyen B; Russell L; Jewett TJ
    Front Cell Infect Microbiol; 2016; 6():84. PubMed ID: 27602332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and targeting of secreted proteins from Chlamydia trachomatis.
    Bauler LD; Hackstadt T
    J Bacteriol; 2014 Apr; 196(7):1325-34. PubMed ID: 24443531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion Membrane Growth and Composition Are Altered by Overexpression of Specific Inclusion Membrane Proteins in Chlamydia trachomatis L2.
    Olson-Wood MG; Jorgenson LM; Ouellette SP; Rucks EA
    Infect Immun; 2021 Jun; 89(7):e0009421. PubMed ID: 33875478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis Type III Secretion Proteins Regulate Transcription.
    Hanson BR; Slepenkin A; Peterson EM; Tan M
    J Bacteriol; 2015 Oct; 197(20):3238-44. PubMed ID: 26216849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
    Dai W; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces
    Cossé MM; Barta ML; Fisher DJ; Oesterlin LK; Niragire B; Perrinet S; Millot GA; Hefty PS; Subtil A
    Front Cell Infect Microbiol; 2018; 8():145. PubMed ID: 29868501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
    Hower S; Wolf K; Fields KA
    Mol Microbiol; 2009 Jun; 72(6):1423-37. PubMed ID: 19460098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III Secretion in
    Rucks EA
    Microbiol Mol Biol Rev; 2023 Sep; 87(3):e0003423. PubMed ID: 37358451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma 54-Regulated Transcription Is Associated with Membrane Reorganization and Type III Secretion Effectors during Conversion to Infectious Forms of Chlamydia trachomatis.
    Soules KR; LaBrie SD; May BH; Hefty PS
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900805
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of chlamydial T3SS inhibitors through virtual screening against T3SS ATPase.
    Grishin AV; Luyksaar SI; Kapotina LN; Kirsanov DD; Zayakin ES; Karyagina AS; Zigangirova NA
    Chem Biol Drug Des; 2018 Mar; 91(3):717-727. PubMed ID: 29068165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus.
    Hobolt-Pedersen AS; Christiansen G; Timmerman E; Gevaert K; Birkelund S
    FEMS Immunol Med Microbiol; 2009 Oct; 57(1):46-58. PubMed ID: 19682078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Floxed-Cassette Allelic Exchange Mutagenesis Enables Markerless Gene Deletion in Chlamydia trachomatis and Can Reverse Cassette-Induced Polar Effects.
    Keb G; Hayman R; Fields KA
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30224436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies.
    Jamison WP; Hackstadt T
    Microb Pathog; 2008; 45(5-6):435-40. PubMed ID: 18984037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.